English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech BioTech
亚太地区细胞与基因研究:Novotech 的增长速度比世界其它地区快 50%
Feb 04, 2023 07:00 HKT
亞太地區細胞與基因研究:Novotech 的增長速度比世界其它地區快 50%
Feb 04, 2023 07:00 HKT
아시아 태평양 지역 세포유전자 연구: 노보텍이 세계의 나머지 모든 기관들보다 50% 더 빠르게 성장
Feb 04, 2023 07:00 HKT
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW
Feb 03, 2023 13:00 HKT
欧康维视研发的治疗干眼症的I类新药OT-202 I期临床试验完成
Feb 03, 2023 10:03 HKT
歐康維視研發的治療乾眼症的I類新藥OT-202 I期臨床試驗完成
Feb 03, 2023 10:02 HKT
Ocumension Therapeutics Announces The Completion Of The Phase I Clinical Trial Of Its Class I New Drug For The Treatment Of Dry Eye -- OT-202
Feb 03, 2023 10:01 HKT
欧康维视自研新药OT-101于中国完成完成受试者入组
Feb 01, 2023 10:02 HKT
歐康維視自研新藥OT-101於中國完成完成受試者入組
Feb 01, 2023 10:01 HKT
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China
Feb 01, 2023 10:00 HKT
Cantor Fitzgerald首次覆盖 普瑞健康予“增持”评级
Jan 26, 2023 12:21 HKT
Cantor Fitzgerald首次覆蓋 普瑞健康予“增持”評級
Jan 26, 2023 12:19 HKT
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
Jan 26, 2023 12:16 HKT
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Jan 12, 2023 15:00 HKT
Novotech Acquires European CRO, Strengthens Global Operations
Jan 12, 2023 15:00 HKT
Novotech 收购美国药物开发咨询公司 CBR International
Jan 12, 2023 15:00 HKT
Novotech 收購美國藥物開發諮詢公司 CBR International
Jan 12, 2023 15:00 HKT
Novotech 收购欧洲 CRO——加强全球运营
Jan 12, 2023 15:00 HKT
Novotech 收購歐洲 CRO——加強全球運營
Jan 12, 2023 15:00 HKT
노보텍, 미국 기반의 의약품 개발 컨설팅 회사인 CBR 인터내셔널 인수
Jan 12, 2023 15:00 HKT
Next >>
Copyright © 2023 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: